Clinical Trial: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: Influenza
Study Type: INTERVENTIONAL
Official Title: VRC 326 (001614): A Phase I Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adul
Brief Summary:
Background:Influenza (flu) virus causes 3 to 5 million cases of severe illness and up to 650,000 deaths per year worldwide.Current vaccines work well against single strains of flu virus.But no single vaccine works well against all flu viruses that can cause illness.Objective:To test an experimental flu vaccine (FluMos-v2) in healthy adults.Eligibility:Healthy adults aged 18 to 50 years.Design:Participants will have 11 clinic visits in 10 months.They must agree not to get a licensed flu vaccine while taking part in…
Read more